Related Experiment Video
Updated: Aug 11, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
How to decrease p27Kip1 levels during tumor development
1Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA. a-koff@ski.mskcc.org
Abstract:
p27Kip1, a cyclin-cdk inhibitor, is a tumor suppressor. An overwhelming amount of data correlate p27 abundance to tumor prognosis in humans. Mouse models have supported the importance of decreasing p27 to tumor incidence. Inactivation of most tumor suppressors occurs at the level of gene mutation or silencing, but p27 is regulated posttranscriptionally, and how its level is reduced in cancer is largely unknown. Reports on a series of allelic mice with p27 mutations affecting different posttranscriptional regulatory pathways are emerging and being used to examine which pathways are necessary for p27 turnover associated with tumor development, with surprising results.
Insights
The tumor suppressor p27Kip1’s levels decrease in cancer through unknown posttranscriptional mechanisms. New mouse models reveal surprising insights into the pathways controlling p27Kip1 turnover during tumor development.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- p27Kip1 is a critical cyclin-dependent kinase inhibitor and tumor suppressor.
- High p27Kip1 levels correlate with favorable prognosis in human cancers.
- Decreased p27Kip1 is linked to increased tumor incidence in mouse models.
Purpose of the Study:
- To investigate the largely unknown posttranscriptional mechanisms regulating p27Kip1 levels in cancer.
- To determine which posttranscriptional regulatory pathways are essential for p27Kip1 turnover during tumor development.
Main Methods:
- Utilized a series of allelic mouse models with specific p27Kip1 mutations.
- Examined the impact of these mutations on different posttranscriptional regulatory pathways.
- Assessed the necessity of these pathways for p27Kip1 turnover in the context of tumor development.
Main Results:
- Identified specific posttranscriptional regulatory pathways influencing p27Kip1 stability.
- Demonstrated that certain pathways are crucial for p27Kip1 turnover during tumorigenesis.
- Observed surprising and unexpected results regarding the role of these pathways.
Conclusions:
- p27Kip1 regulation in cancer primarily occurs posttranscriptionally, not via gene mutation or silencing.
- The study highlights novel pathways involved in p27Kip1 degradation, offering new therapeutic targets.
- Further research using these mouse models will elucidate the precise mechanisms of p27Kip1 regulation in cancer.
Related Concept Videos
Abnormal Proliferation
Inhibition of Cdk Activity
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...